블루엠텍

439580KOSDAQ기타 전문 도매업

32.5 / 100

Reference Date: 2026-07-24

Financial Score7.0 / 40

News Sentiment12.5 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 13.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BlueEmtek operates pharmaceutical distribution platforms such as BluePharmKorea and KoolPharm, selling specialized medications to hospitals and pharmacies. The company also provides the online order management system 'BOS' and cold chain logistics solutions to enhance pharmaceutical distribution efficiency, and operates a medical staffing platform called BlueDoc.

Number of Employees

98people

Average Salary

48.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 12.754.0Point

PBR

1.29Industry Average 0.580.0Point

2.2x industry avg (risky)

ROE

-9.81Industry Average 2.090.0Point

Well below industry avg

Debt Ratio

20.30Industry Average 7.870.0Point

2.6x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲28.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼270.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
[메자닌 투자파일] 'BW 차환' 블루엠텍, 지배력 방어는 숙제
블루엠텍은 BW 차환을 통해 자금 조달 계획을 발표했으나, 본업 적자와 재무 부담으로 인해 직접적인 긍정적 영향은 제한적이다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 1,708Won52-week high 6,42052-week low 1,595

1-month return1.0Point

1m -13.65% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득 (제3회차)2026-07-15
Neutral주식등의대량보유상황보고서(약식)2026-07-14
Neutral주식등의대량보유상황보고서(약식)2026-07-13
Neutral증권발행결과(자율공시) (제4회차 BW)2026-07-10
Neutral[기재정정]주식등의대량보유상황보고서(약식)2026-07-07